Showing 670 results
-
Media Release /
-
Media Release /Gilenya is the first approved oral treatment indicated for relapsing forms of MS in the US, a major advance for people with this diseaseGilenya showed superior efficacy by reducing relapses by 52% at…
-
Media Release /
-
Media Release /-- Tekamlo combines in a single-pill the only approved direct renin inhibitor, Tekturna, with the widely prescribed calcium channel blocker, amlodipine-- Data showed Tekamlo significantly reduced…
-
Media Release /
-
Media Release /- The Novartis US affiliate, Novartis Pharmaceuticals Corporation (NPC), is committed to active and progressive policies and programs supporting the advancement of women in the sales force- NPC…
-
Media Release /
-
Media Release /- Alabama Supreme Court directs entry of final judgment in favor of NPC- Alabama Supreme Court ruling confirms State of Alabama's claims unfounded- NPC pleased by ruling, as the company reported true…
-
Media Release /
-
Media Release /- Tekturna HCT combines the only approved direct renin inhibitor, Tekturna®, with widely used diuretic, hydrochlorothiazide, in a single pill- Data show combination of Tekturna and…
